Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kymera Therapeutics (KYMR) Return on Assets (2020 - 2026)

Kymera Therapeutics (KYMR) has disclosed Return on Assets for 7 consecutive years, with 0.21% as the latest value for Q1 2026.

  • For Q1 2026, Return on Assets rose 8.0% year-over-year to 0.21%; the TTM value through Mar 2026 reached 0.21%, up 8.0%, while the annual FY2025 figure was 0.26%, 8.0% up from the prior year.
  • Return on Assets hit 0.21% in Q1 2026 for Kymera Therapeutics, up from 0.25% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.21% in Q1 2026 and bottomed at 0.33% in Q3 2023.
  • Average Return on Assets over 5 years is 0.26%, with a median of 0.26% recorded in 2024.
  • Year-over-year, Return on Assets fell -13bps in 2022 and then grew 11bps in 2024.
  • Kymera Therapeutics' Return on Assets stood at 0.26% in 2022, then decreased by -13bps to 0.29% in 2023, then grew by 11bps to 0.26% in 2024, then increased by 6bps to 0.25% in 2025, then grew by 14bps to 0.21% in 2026.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.21%, 0.25%, and 0.3% for Q1 2026, Q4 2025, and Q3 2025 respectively.